Lamdong Pharmaceutical JSC (HNX:LDP)

HNX:LDP Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Apr 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Market Capitalization	165,141	129,572	201,980	66,056	476,368	169,909
Market Cap Growth	-29.28%	-35.85%	205.77%	-86.13%	180.37%	-15.23%
Enterprise Value	208,251	161,439	252,243	125,152	488,077	262,363
Last Close Price	13000.00	10200.00	15900.00	5200.00	37500.00	17640.36
PE Ratio	21.29	18.73	-	-	12.58	17.73
PS Ratio	0.71	0.59	1.09	0.35	2.94	0.45
PB Ratio	1.65	1.31	2.19	0.59	3.11	1.78
P/TBV Ratio	1.65	1.31	2.19	0.59	3.12	1.87
P/FCF Ratio	401.26	22.21	33.79	-	22.27	150.08
P/OCF Ratio	37.57	14.78	33.46	-	16.38	10.14
EV/Sales Ratio	0.89	0.74	1.36	0.67	3.02	0.69
EV/EBITDA Ratio	9.97	8.03	-	-	-	41.10
EV/EBIT Ratio	14.46	12.16	-	-	-	-
EV/FCF Ratio	506.01	27.67	42.20	-	22.82	231.74
Debt / Equity Ratio	0.64	0.55	0.71	0.63	0.21	1.06
Debt / EBITDA Ratio	3.06	2.74	-	-	-	15.77
Debt / FCF Ratio	155.10	9.43	11.04	-	1.51	88.91
Asset Turnover	1.17	1.09	0.88	0.84	-	1.38
Inventory Turnover	4.00	3.54	3.18	2.71	-	2.93
Quick Ratio	0.46	0.43	0.43	0.45	1.52	0.48
Current Ratio	1.48	1.48	1.39	1.40	2.47	1.05
Return on Equity (ROE)	8.04%	7.22%	-19.63%	-29.26%	-	10.45%
Return on Assets (ROA)	4.49%	4.13%	-3.65%	-7.12%	-	-0.56%
Return on Capital (ROIC)	5.62%	5.31%	-4.52%	-8.57%	-	-0.88%
Return on Capital Employed (ROCE)	14.10%	13.10%	-	-	-	-
Earnings Yield	4.70%	5.34%	-9.95%	-58.88%	7.95%	5.64%
FCF Yield	0.25%	4.50%	2.96%	-70.73%	4.49%	0.67%
Buyback Yield / Dilution	0.01%	-	-0.01%	0.02%	-62.22%	-0.04%
Total Shareholder Return	0.01%	-	-0.01%	0.02%	-62.22%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.